Predict your next investment

Corporation
wellpartner.com

See what CB Insights has to offer

About Wellpartner

Wellpartner is a provider of complete 340B optimization solutions for a wide variety of safety-net hospitals and clinics. Wellpartner also dispenses pharmaceutical and specialty products through its wholly-owned URAC-, ACHC-, and VIPPS-accredited specialty pharmacy.

Wellpartner Headquarter Location

20800 S.W. 115th Avenue Suite 100

Tualatin, Oregon, 97062,

United States

877-231-6346

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Wellpartner News

CVS forced hospitals to drop CaptureRx services, lawsuit charges

Jan 23, 2019

Written by Alia Paavola | January 23, 2019 | Print  | Email CaptureRx, a San Antonio-based 340B program administrator, is suing CVS Health for allegedly violating antitrust laws by engaging in anticompetitive behavior, according to Express News. In the lawsuit filed Jan.18 in federal court, CaptureRx claims CVS required hospitals and health centers working with CVS pharmacies to switch to Wellpartner, a CVS subsidiary providing services for the 340B program. According to the lawsuit, at least 40 hospitals and clinics have terminated their agreements with CaptureRx, and others indicated they will not renew once their contract expires. Wellpartner and CaptureRx are competitors. "As CVS continues to pressure customers with its mandates, CaptureRx suspects that most of its [healthcare provider] customers will cease doing business with CaptureRx,” the suit alleges. "But for CVS’ unlawful ties, these customers would have remained with CaptureRx." CaptureRx is a 340B administrator for more than 500 hospitals and health centers. In addition, more than 3,500 specialty, independent and regional national pharmacies are in the network. CVS spokesperson Mike DeAngelis said the lawsuit has no merit, adding that "it appears that CaptureRx is threatened by new competition and is trying to use unfounded antitrust allegations to stall the growth of an emerging competitor, Wellpartner."

Wellpartner Acquisitions

2 Acquisitions

Wellpartner acquired 2 companies. Their latest acquisition was 340B SMART on March 06, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/6/2017

Acquired

1

2/12/2016

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/6/2017

2/12/2016

Investment Stage

Companies

Subscribe to see more

Valuation

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.